Correlation of Body Fat Composition and Metabolic Indicators with Metabolic-associated Fatty Liver Disease in a Non-obese Population

Correlation of Body Fat Composition and Metabolic Indicators with Metabolic-associated Fatty Liver Disease in a Non-obese Population

Background The prevalence of metabolic-associated fatty liver disease (MAFLD) has increased rapidly. And there is no conclusion on body fat composition, characteristics of metabolic indicators, and their predictive values for MAFLD in non-obese populations. Objective To identify the risk factors for...

Full description

Bibliographic Details
Main Author:	WANG Yingjie, CHENG Haoran, ZHOU Weihong
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2023-02-01
Series:	Zhongguo quanke yixue
Subjects:	fatty liver\|nonobese metabolic fatty liver disease\|blood lipid\|blood glucose\|uric acid\|visceral fat\|risk factors\|sensitivity\|specificity\|root cause analysis\|diagnosis
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/zx20220573.pdf

Similar Items

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
by: Tingfeng Wu, et al.
Published: (2021-11-01)

Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
by: Noriyo Urata, et al.
Published: (2020-09-01)

Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
by: Congxiang Shao, et al.
Published: (2023-01-01)

The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease
by: Jie He, et al.
Published: (2022-08-01)

Visceral and subcutaneous fat, muscle mass, and liver volume as noninvasive predictors of the progress of non-alcoholic fatty liver disease
by: Omar M. Mahmoud, et al.
Published: (2023-01-01)

The effects of medicinal and food homologous substances on blood lipid and blood glucose levels and liver function in patients with nonalcoholic fatty liver disease: a systematic review of randomized controlled trials
by: Qian Zhang, et al.
Published: (2023-08-01)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
by: Shahinul Alam, et al.
Published: (2021-11-01)

Is subclinical atherosclerosis associated with visceral fat and fatty liver in adolescents with type 1 diabetes?
by: Hoda Atwa, et al.
Published: (2018-03-01)

The case for FAT10 as a novel target in fatty liver diseases
by: Madushika M. Wimalarathne, et al.
Published: (2022-11-01)

Prevalence of Steatotic Liver Disease Based on a New Nomenclature in the Japanese Population: A Health Checkup-Based Cross-Sectional Study
by: Takao Miwa, et al.
Published: (2024-02-01)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
by: Ioanna Aggeletopoulou, et al.
Published: (2023-08-01)

Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement
by: Zengzhe Zhu, et al.
Published: (2022-09-01)

Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
by: Hongmei Yan, et al.
Published: (2021-01-01)

Comparison of novel visceral obesity indexes with traditional obesity measurements in predicting of metabolically unhealthy nonobese phenotype in hemodialysis patients
by: Chaomin Zhou, et al.
Published: (2021-12-01)

Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humans
by: Aida Medina-Urrutia, et al.
Published: (2020-05-01)

Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women
by: Jongmin Baek, et al.
Published: (2020-07-01)

Association between Serum Potassium and Metabolic-associated Fatty Liver Disease in Patients with Primary Gout
by: WANG Junwei, LIN Lingjun, SONG Linling, CHENG Xiaocui, NIE Xiuling
Published: (2023-04-01)

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
by: Francesco Massimo Perla, et al.
Published: (2017-06-01)

Correlation between the Severity of Metabolic-associated Fatty Liver Disease and Thyroid Nodules
by: BAI Yitong, LIN Lianjie, PEI Dongmei
Published: (2023-09-01)

Liver Fat Storage Is a Better Predictor of Coronary Artery Disease than Visceral Fat
by: Maamoun Basheer, et al.
Published: (2023-07-01)

Food Intake and Visceral Fat Deposition are Risk Factors of Incidence and Severity of Non-Alcoholic Fatty Liver Disease
by: Risky Ika Riani, et al.
Published: (2017-12-01)

Changes in Physiological Parameters, Lipid Metabolism, and Expression of MicroRNAs in Genetically Improved Farmed Tilapia (Oreochromis niloticus) With Fatty Liver Induced by a High-Fat Diet
by: Yi-Fan Tao, et al.
Published: (2018-10-01)

Correlation between Estimated Glucose Disposal Rate and Metabolism-associated Fatty Liver Disease in Type 2 Diabetes
by: KONG Dexian, XING Yuling, SUN Wenwen, ZHANG Zhimin, ZHOU Fei, MA Huijuan
Published: (2023-09-01)

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity
by: I. V. Logacheva, et al.
Published: (2019-01-01)

Abdominal Fat and Metabolic Health Markers but Not PNPLA3 Genotype Predicts Liver Fat Accumulation in Response to Excess Intake of Energy and Saturated Fat in Healthy Individuals
by: Fredrik Rosqvist, et al.
Published: (2020-12-01)

Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents
by: Anajás S. Cardoso, et al.
Published: (2013-07-01)

Metabolic abnormalities, liver and body fat in American versus Chinese patients with non‐alcoholic fatty liver disease
by: Wei Zhang, et al.
Published: (2022-08-01)

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Veera Houttu, et al.
Published: (2021-07-01)

Betaine Promotes Fat Accumulation and Reduces Injury in Landes Goose Hepatocytes by Regulating Multiple Lipid Metabolism Pathways
by: Jiying Liu, et al.
Published: (2022-06-01)

Saponins of Tomato Extract Improve Non-Alcoholic Fatty Liver Disease by Regulating Oxidative Stress and Lipid Homeostasis
by: Ziming Yang, et al.
Published: (2023-10-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

<b>Analytical methods for evaluation of the fatty acid metabolism in rat liver
by: Eduardo Hideo Gilglioni, et al.
Published: (2018-11-01)

Diagnostic ability using fatty liver and metabolic markers for metabolic‐associated fatty liver disease stratified by metabolic/glycemic abnormalities
by: Akira Okada, et al.
Published: (2023-03-01)

Exploring the Complex Interplay: Fatty Liver Severity, Epicardial Fat Volume, and Coronary Artery Calcification
by: Seyed Kamaledin Hadei, et al.
Published: (2024-03-01)

Lipids, liver and pancreas at the crossroads of metabolic syndrome and obesity epidemics
by: O. V. Efimova, et al.
Published: (2020-12-01)

A Review on Some Biochemical markers in mMetabolic-Associated Fatty Liver Disease
by: Sarah Ashour
Published: (2023-06-01)

Relationship between Non-Alcoholic Fatty Liver Disease and Cardiovascular and Metabolic Risk Indices
by: Şevin Demir, et al.
Published: (2022-07-01)

Effect of inhibiting PDHα1 gene expression on the metabolism of fatty liver cells
by: Xiaoguang Chen, et al.
Published: (2024-01-01)

FGF9 Alleviates the Fatty Liver Phenotype by Regulating Hepatic Lipid Metabolism
by: Fanrong Zhao, et al.
Published: (2022-04-01)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
by: Carolina M. Perdomo, et al.
Published: (2022-10-01)